Get the Stockscreener App
Wells Fargo & Company/Mn's Portfolio and 13F Filing
| Value: | $316.99B |
| Website: | www.wellsfargo.com |
| CIK: | 0000072971 |
| Phone: | 917-260-2077 |
| Address: | 420 Montgomery Street, San Francisco, CA (94163) |
| Latest 13F Filing: | 2020-10-01 |
| # | Stock Name | Symbol | Current Price | Previous Holdings (# Shares) |
Current Holdings (# Shares) |
Current Value | Percent |
|---|---|---|---|---|---|---|---|
| 3701 | ProShares Ultra QQQ | QLD | $81.83 | N/A | 0 | $0 | 0.00% |
| 3702 | ProShares Ultra MidCap400 | MVV | $61.43 | N/A | 0 | $0 | 0.00% |
| 3703 | ProShares Ultra Industrials | UXI | $32.68 | N/A | 0 | $0 | 0.00% |
| 3704 | ProShares Ultra Basic Materials | UYM | $26.77 | N/A | 0 | $0 | 0.00% |
| 3705 | ProShares Ultra Russell2000 | UWM | $36.05 | N/A | 0 | $0 | 0.00% |
| 3706 | ProShares Inflation Expectation | RINF | $33.41 | N/A | 0 | $0 | 0.00% |
| 3707 | Ra Medical Systems, Inc. | RMED | $0.00 | N/A | 54 | $0 | 0.00% |
| 3708 | RPT Realty | RPT | $0.00 | N/A | 270,553 | $0 | 0.00% |
| 3709 | Reality Shares Divcon Dividend Defender ETF | DFND | $39.75 | N/A | 0 | $0 | 0.00% |
| 3710 | Reata Pharmaceuticals, Inc. | RETA | $0.00 | N/A | 7,952 | $0 | 0.00% |
Related 13F Filings:
berkshire hathaway 13f,
sec 13f filing list,
warren buffett 13f,
baker brothers 13f,
fundsmith 13f ,
valueact 13f,
greenlight capital 13f,
dorsey asset management 13f,
ra capital 13f,
dragoneer 13f,
vanguard group inc 13f,
hillhouse 13f,
citadel 13f,
morgan stanley 13f,
spruce house 13f,
fmr llc 13f,
sachem head 13f,
duquesne capital 13f,
maverick capital 13f,
soros fund management 13f,
light street capital 13f,
bronte capital 13f,
corvex 13f,
adw capital 13f,
arlington value capital 13f,
greenhaven road capital 13f,
fisher investments 13f,
bares capital management 13f,
generation investment management 13f,
giverny capital 13f,
goldman sachs 13f,
omega advisors 13f,
thomson reuters 13f